Shares of PLx Pharma Inc. (NASDAQ: PLXP) climbed 31.03% Friday.

As of 12:05:59 est, PLx Pharma sits at $2.56 and has climbed $0.63 so far today.

PLx Pharma has moved 39.76% over the last 30 days and has a YTD change of 74.66% based on the previous close.

The company is set to release earnings on 2022-05-13.

For technical charts, analysis, and more on PLx Pharma visit the company profile.

About PLx Pharma Inc.

PLx Pharma Inc. is a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the gastrointestinal (GI) tract. PLx believes this has the potential to improve the absorption of many drugs currently on the market or in development, and to reduce the risk of stomach erosions and ulcers associated with aspirin and ibuprofen, and potentially other drugs.

To get more information on PLx Pharma Inc. and to follow the company's latest updates, you can visit the company's profile page here: PLx Pharma Inc.'s Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

Big Lots Down 18% in Premarket Trading Friday on Surprise Missed Earnings

Modine Posts Strong Rebound in Fiscal Q4, Raises 2023 Guidance

Dollar Tree Posts Record First Quarter, Leads Nasdaq Gainers

Kohl's Still in Play To Be Acquired

Chinook Therapeutics Raises $105 Million for Kidney Disease Therapies

Market Conditions Driving Higher Base Level for VIX Volatility Index

Will New AT&T, Dish Co-opetition Deal Work: Jeff Kagan

Cisco Down 12% in Premarket Trading Thursday After Top Line Miss and Lower Forecast